Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Mucosal Atomization Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The mucosal atomization devices market size has grown strongly in recent years. It will grow from $0.79 in 2023 to $0.87 in 2024 at a compound annual growth rate (CAGR) of 9.9%. The mucosal atomization devices market size is expected to see strong growth in the next few years. It will grow to $1.27 in 2028 at a compound annual growth rate (CAGR) of 10.0%.
The growth observed in the historical period can be attributed to factors such as the application of mucosal atomization devices in emergency medicine, anesthesia procedures, pediatric care, pain management, and dental procedures.
The anticipated growth in the forecast period can be attributed to factors such as the use of mucosal atomization devices in the treatment of chronic diseases, the expansion of telemedicine practices, the adoption of precision medicine, the application in cosmetic procedures, enhancing patient comfort, and potential use in autonomous vehicles.
Key trends expected during this period include the promotion of sustainable and eco-friendly practices in the industry, the implementation of digital mortuary management systems, the introduction of green burial options, the rise of remote viewing and streaming services for funeral events, and the emergence of hybrid funeral services that integrate traditional and modern elements.
The growth of the mucosal atomization devices market is driven by the increasing prevalence of allergic rhinitis worldwide. Allergic rhinitis, characterized by symptoms affecting the nose due to exposure to allergens like pollen, dust, or animal dander, prompts the use of mucosal atomization devices for chronic rhinosinusitis treatment, delivering budesonide as a topical nasal steroid spray.
Seasonal allergic rhinitis, commonly known as hay fever, is a prevalent allergic condition, affecting approximately 7.7% of adults and 7.2% of children in the United States, as reported in the Allergy Capital Report 2022. Consequently, the rising incidence of allergic rhinitis globally contributes to the growth of the mucosal atomization devices market.
The anticipated growth in the elderly population is set to propel the mucosal atomization device market forward. Defined as individuals aged 65 and above, the elderly population is expected to play a significant role in driving the demand for mucosal atomization devices. With aging, susceptibility to chronic conditions such as allergic rhinitis and sinusitis increases, necessitating the use of mucosal atomization devices for treatment.
Data from America's Health Rankings indicates that in the United States, over 56 million adults aged 65 and above constitute around 16.9% of the total population. The projection of more than 73.1 million older individuals by 2030, as the baby boomer generation ages, further emphasizes the role of the elderly population in fueling the mucosal atomization device market.
Strategic partnerships emerge as a key trend gaining popularity in the mucosal atomization devices market. Leading companies in this sector are increasingly entering partnerships to strengthen their market positions. For instance, Pulmodyne Inc., a US-based provider of drug atomization delivery, collaborated with Alcove Manufacturing and Distribution Inc., a UK-based company, in October 2021. Through this partnership, the EZ-Spray Atomization System is set to be distributed by Pulmodyne, leveraging its existing channels. The collaboration aims not only to enhance distribution but also to drive innovation in the industry, allowing both seasoned companies to optimize product designs promptly.
Major companies in the mucosal atomization device market are adopting strategic partnerships to facilitate distribution expansion, integrate manufacturing capabilities, and jointly develop new atomization technologies. In another example from October 2021, Pulmodyne, Inc. and Alcove Manufacturing and Distribution, Inc. announced their partnership, focusing on the distribution of the EZ-Spray Atomization System and fostering innovation within the industry. This collaborative effort enables the two experienced companies to quickly optimize product designs and advance the field.
North America was the largest region in the mucosal atomization devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The countries covered in the mucosal atomization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
Key Topics Covered:
1. Executive Summary
2. Mucosal Atomization Devices Market Characteristics
3. Mucosal Atomization Devices Market Trends And Strategies
4. Mucosal Atomization Devices Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Mucosal Atomization Devices Market Size and Growth
5.1. Global Mucosal Atomization Devices Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Mucosal Atomization Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Mucosal Atomization Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Mucosal Atomization Devices Market Segmentation
6.1. Global Mucosal Atomization Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Nasal Atomization Devices
- Fiber-Optic Atomization Devices
- Laryngo-Tracheal Atomization Devices
- Bottle Atomizer Devices
6.2. Global Mucosal Atomization Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Gas Propelled Atomization Devices
- Electrical Atomization Devices
6.3. Global Mucosal Atomization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
7. Mucosal Atomization Devices Market Regional And Country Analysis
7.1. Global Mucosal Atomization Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Mucosal Atomization Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
A selection of companies mentioned in this report includes
- Teleflex Incorporated
- DeVilbiss Healthcare LLC
- Becton Dickinson and Company
- Cook Medical LLC
- Medica Holdings LLC
- Life-Assist Inc.
- Pulmodyne Inc.
- Alcove Manufacturing and Distribution Inc.
- LMA North America Inc.
- Medline Industries Inc.
- Medtronic plc
- Smiths Medical Inc.
- Vyaire Medical Inc.
- Westmed Inc.
- Mercury Medical
- SunMed LLC
- Salter Labs
- Armstrong Medical Industries Inc.
- VBM Medizintechnik GmbH
- Intersurgical Ltd.
- Flexicare Medical Limited
- Medovations Inc.
- Medis Medical Imaging Systems
- Medisize BV
- Atom Medical Corporation
- BLS Systems Limited
- Bona Pharma Inc.
- Central Admixture Pharmacy Services Inc.
- Dali Medical Devices Co. Ltd.
- Dynarex Corporation
For more information about this report visit https://www.researchandmarkets.com/r/vjc3ap
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
